XML 57 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Transaction and Reverse Recapitalization - Additional Information (Details)
3 Months Ended 6 Months Ended
May 19, 2022
Days
$ / shares
shares
Nov. 17, 2020
USD ($)
$ / shares
shares
Oct. 13, 2020
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
$ / shares
Business Acquisition [Line Items]            
Common stock, par value       $ 0.0001 $ 0.0001 $ 0.0001
Number of shares placed into escrow | shares 3,150,000     3,150,000 3,150,000  
Earn-out trigger, weighted average share price $ 12.50          
Earn-out trigger, threshold trading days | Days 20          
Earn-out trigger, threshold consecutive trading days | Days 30          
Number of business days for releasing earn-out shares following achievement of Earn-out trigger 10 days          
Number Of Busines Days For Releasing Earn-Out Shares Following Achievement Of Earn-Out Trigger 10 days          
Estimated fair value per share of Earn-Out Shares         $ 8.63  
Estimated fair value of Earn-Out Shares | $         $ 27,200,000  
Earnout consideration description         If the Earn-Out Trigger is not achieved for the two-year period following the Closing Date, the Earn-Out Shares will be cancelled and returned to treasury. The contingent obligation to issue Earn-Out Shares to Legacy Comera stockholders is considered indexed to the Company’s own stock and meets the equity classification under ASC 815.  
Common stock consideration per share $ 12.50          
Common stock exercised | shares         1,385,310  
Convertible preferred stock, par value       $ 0.0001 $ 0.0001  
Direct and incremental cost related to the equity issuance | $       $ 7,500,000 $ 7,500,000  
Amount of transaction costs exceeded equity issuance cost | $       6.6 6.6  
General and Administrative            
Business Acquisition [Line Items]            
Transaction costs incurred | $       $ 1,500,000 $ 1,500,000  
Private Placement | Maxim Group LLC.            
Business Acquisition [Line Items]            
Maxim private placement, amount | $     $ 1,000,000.0      
Maxim private placement, value per share     $ 10.25      
Maxim private placement, shares | shares     97,561   97,561  
Series A Convertible Preferred Stock            
Business Acquisition [Line Items]            
Convertible preferred stock, par value       $ 0.0001 $ 0.0001  
Transaction noncash expenses related to shares issued | $         $ 4,400,000  
Underwriting Agreement | Series A Convertible Preferred Stock            
Business Acquisition [Line Items]            
Convertible preferred stock, par value   $ 0.0001        
Share issuance pursuant to services owed, value | $   $ 3,400,000 $ 910,000      
Share issuance pursuant to services owed | shares   3,395 910      
Comera Merger            
Business Acquisition [Line Items]            
Common stock, par value 0.0001          
Comera Merger | Comera Life Sciences, Inc.            
Business Acquisition [Line Items]            
Common stock, par value $ 0.001          
OTR Merger            
Business Acquisition [Line Items]            
Conversion basis         Upon the Closing, by virtue of the OTR Merger, all shares of common stock of OTR issued and outstanding immediately prior to the Closing were converted on a one-to-one basis into the right to receive shares of CLS Holdings Common Stock  
Conversion ratio 1          
Common stock exercised | shares 9,769,363          
Common stock issued | shares 3,472,654          
OTR Acquisition Corp            
Business Acquisition [Line Items]            
Date of acquisition         May 19, 2022